Pretax income is the income that a company earns before paying income taxes. Pharma-Bio Serv's pretax income for the
three
months ended in Jan. 2024 was $-0.26 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Jan. 2024 was $0.85 Mil.
Pharma-Bio Serv's pretax margin was -10.84%.
During the past 13 years, Pharma-Bio Serv's highest Pretax Margin was 11.40%. The lowest was -9.33%. And the median was 8.12%.
Pharma-Bio Serv Pre-Tax Income Historical Data
The historical data trend for Pharma-Bio Serv's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Pharma-Bio Serv's Pre-Tax Income
For the Health Information Services subindustry, Pharma-Bio Serv's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharma-Bio Serv's Pre-Tax Income Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pharma-Bio Serv's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Pharma-Bio Serv's Pre-Tax Income falls into.
Pharma-Bio Serv Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Pharma-Bio Serv's Pretax Income for the fiscal year that ended in Oct. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.85 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharma-Bio Serv (OTCPK:PBSV) Pre-Tax Income Explanation
Pharma-Bio Serv's Pretax Margin for the quarter that ended in Jan. 2024 is calculated as
During the past 13 years, Pharma-Bio Serv's highest Pretax Margin was 11.40%. The lowest was -9.33%. And the median was 8.12%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharma-Bio Serv Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Pharma-Bio Serv's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Pharma-Bio Serv (Pharma-Bio Serv) Business Description
Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It has three reportable segments: Puerto Rico technical compliance consulting which is the key revenue driver; United States technical compliance consulting; and Europe technical compliance consulting. The company offers solutions to the pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PBSV has been successfully added to your 